Research-grade Chonluten (Glu-Asp-Gly) is available for laboratory procurement to evaluate its specific role in modulating inflammatory signaling pathways, including the downregulation of Interleukin-6 (IL-6) in cellular and tissue models. Pricing for this short bioregulatory peptide varies based on analytical purity, lot-specific verification, and order volume, with PX1 Research providing fully characterized, HPLC- and mass spectrometry-validated compounds strictly for non-clinical, in vitro, and animal research.
Research-grade Chonluten (Glu-Asp-Gly) is available for laboratory procurement to evaluate its specific role in modulating inflammatory signaling pathways, including the downregulation of Interleukin-6 (IL-6) in cellular and tissue models. Pricing for this short bioregulatory peptide varies based on analytical purity, lot-specific verification, and order volume, with PX1 Research providing fully characterized, HPLC- and mass spectrometry-validated compounds strictly for non-clinical, in vitro, and animal research.
When principal investigators seek to buy interleukin6 reduction chonluten for cellular assays, evaluating the relationship between chemical purity, documented analysis, and price structure is paramount. Chonluten is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-glycine (Glu-Asp-Gly). Derived from peptide bioregulator research originally focused on pulmonary and respiratory tissues, it has drawn significant interest in immunological and biochemical studies targeting pro-inflammatory cytokine expression.
Interleukin-6 (IL-6) is a key pleiotropic cytokine implicated in acute and chronic inflammatory cascades, tissue degeneration, and cellular senescence models. Investigating how synthetic bioregulators alter nuclear factor kappa B (NF-κB) transcription, chromatin accessibility, and downstream cytokine production requires highly characterized research compounds. Laboratories ordering Chonluten must ensure that the peptide is free of organic impurities, residual solvents, and bacterial endotoxins that could skew baseline inflammatory responses in culture.
In vitro and ex vivo models indicate that short synthetic peptides interact directly with DNA promoter regions and histone proteins to modulate gene expression. Preclinical studies suggest that Chonluten penetrates nuclear membranes to bind specific nucleotide sequences, subsequently downregulating genes associated with pro-inflammatory signaling pathways. This transcriptional modulation often manifests as a measurable reduction in pro-inflammatory factors such as Interleukin-6 (IL-6), Interleukin-1β (IL-1β), and Tumor Necrosis Factor-alpha (TNF-α).
Furthermore, research indicates that Chonluten helps stabilize bronchial epithelium cell function under conditions of oxidative stress or lipopolysaccharide (LPS) challenge. By shifting cellular dynamics away from hyper-inflammatory signaling, researchers can quantify the precise kinetics of IL-6 gene suppression, protein translation, and downstream STAT3 pathway activation. Understanding these fundamental mechanisms provides valuable insights into bioregulatory peptide activity across broad cytokine modulation research.
The scientific rationale for acquiring Chonluten stems from extensive preclinical literature investigating tissue-specific peptide bioregulators. In rodent models subjected to acute lung injury or environmental toxico-chemical exposure, administration of synthetic short peptides resulted in a statistically significant decline in bronchoalveolar lavage fluid (BALF) IL-6 concentrations compared to non-treated control cohorts.
In vitro assays utilizing human bronchial epithelial cell cultures demonstrated that exposure to Glu-Asp-Gly suppressed hyper-activation of inflammatory signaling under induced hypoxia. Researchers measured both mRNA expression via quantitative PCR and secreted cytokine protein levels via enzyme-linked immunosorbent assay (ELISA). The consistent finding across these preclinical trials is that Chonluten does not act as a complete immunosuppressant, but rather functions as a biological homeostatic agent, restoring baseline IL-6 expression without compromising core cellular defense mechanisms. Detailed analysis of these papers is available through our central peptides research library.
Chonluten is part of a broader class of short, tissue-targeted peptide bioregulators evaluated for anti-inflammatory and cellular protective effects. When designing research protocols, investigators often evaluate Chonluten alongside related short-chain peptides to compare target selectivity and potency across diverse tissue types.
For instance, while Chonluten focuses primarily on pulmonary and bronchial epithelial cytokine suppression, Thymogen (Glu-Trp) is predominantly studied for systemic immunomodulatory effects and T-cell differentiation. Similarly, Bronchogen (Ala-Glu-Asp-Leu) is evaluated for bronchial tissue restructuring and mucus hypersecretion control, while Epitalon (Ala-Glu-Asp-Gly) is investigated for telomerase activation and neuroendocrine modulation. Researchers can explore the full spectrum of available compounds in our all peptides directory to construct comprehensive comparative panels.
The cost of commercial research peptides fluctuates based on synthesis method, scale, purity threshold, and quality control validation. While low-grade commercial formulations may seem cost-effective initially, unverified compounds frequently contain synthesis truncated sequences, residual trifluoroacetic acid (TFA) salts, and high endotoxin loads that alter IL-6 assay baselines and ruin experimental repeatability.
When assessing the price of Chonluten for IL-6 reduction studies, laboratory buyers should factor in the cost of comprehensive quality verification. PX1 Research ensures optimal price-to-quality performance by manufacturing under strict quality management frameworks, validating every single lot through dual independent testing, and providing complete analytical transparency. For high-throughput screening or multi-phase animal studies, institutional accounts can utilize our wholesale peptide procurement program to secure bulk pricing without compromising analytical rigor.
To guarantee that experimental results reflect genuine peptide kinetics rather than biological contaminants, PX1 Research subjects every batch of Chonluten to rigorous quality control standards in an ISO 17025 accredited laboratory environment:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Confirms physical purity levels exceeding 98.0%, eliminating truncated peptide sequences and leftover reagents. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight (Glu-Asp-Gly, molecular mass ~305.24 g/mol), confirming correct amino acid sequence identity. 3. Chromogenic LAL Endotoxin Testing: Measures bacterial endotoxin levels to ensure values remain well below established limits (<0.01 EU/mg), preventing non-specific IL-6 activation caused by lipopolysaccharide contamination. 4. Residual Solvent & Counter-Ion Analysis: Checks for minimal TFA content to protect sensitive cell lines during in vitro dosing assays.
Proper handling of synthetic tripeptides is crucial for maintaining chemical integrity and preventing enzymatic or thermal degradation prior to assay execution. Chonluten is supplied as a lyophilized (freeze-dried) powder in sealed glass vials under inert gas fill.
For reconstitution, laboratories should utilize sterile, endotoxin-free Bacteriostatic Water or phosphate-buffered saline (PBS, pH 7.4) depending on the specific requirement of the target assay. Reconstitution should involve gentle swirling of the vial rather than aggressive vortexing to avoid shearing forces. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to eliminate damaging freeze-thaw cycles and stored at -20°C or -80°C for long-term stability. Lyophilized vials should be kept desiccated at -20°C away from direct light exposure.
Reliable research requires a dependable supply chain. PX1 Research operates fully compliant US-based synthesis and distribution facilities located in California and Arizona. By controlling the entire manufacturing and quality verification process domestically, we eliminate international customs delays, temperature degradation during extended transit, and batch-to-batch inconsistency.
All orders placed Monday through Friday before our daily cutoff time are processed with same-day shipping. Vials are packaged with protective insulation to preserve chemical integrity throughout transit. Every shipment includes lot-matched Certificates of Analysis (COAs) accessible directly via QR code on the product label or via our online portal.
What is Chonluten studied for in preclinical research?
Chonluten (Glu-Asp-Gly) is studied in preclinical models for its bioregulatory effects on pulmonary tissue, gene expression modulation, and its capacity to reduce pro-inflammatory cytokines such as Interleukin-6 (IL-6) and TNF-alpha under inflammatory or oxidative challenge.
Why is endotoxin testing critical when researching IL-6 reduction with Chonluten?
Bacterial endotoxins (LPS) are potent triggers of Interleukin-6 expression in cell culture. If a research peptide is contaminated with endotoxins, the resulting inflammatory spike will mask or confound any potential IL-6 reducing effects of the peptide itself.
What analytical purity is required for in vitro Chonluten assays?
In vitro cellular assays generally require a minimum peptide purity of 98.0% determined by RP-HPLC, accompanied by Mass Spectrometry sequence confirmation to ensure reliable, reproducible biochemical data.
What factors influence the price of research-grade Chonluten?
Chonluten pricing depends on synthesis method quality, net peptide content, lot-specific analytical validation costs (HPLC, MS, endotoxin testing), packaging standards, and purchase volume.
How should lyophilized Chonluten be stored upon delivery?
Lyophilized Chonluten should be stored at -20°C in a dry, dark environment. Upon reconstitution with sterile buffer, solutions should be divided into single-use aliquots and maintained at -20°C or -80°C.
Does PX1 Research provide bulk or institutional pricing for Chonluten?
Yes, PX1 Research offers institutional pricing structures for bulk orders and high-throughput research accounts via our wholesale portal.
Where does PX1 Research ship Chonluten orders from?
All PX1 Research compounds are manufactured and shipped directly from our US fulfillment centers in California and Arizona, offering same-day dispatch for weekday orders.
Can Chonluten be used for human health or therapeutic purposes?
No. Chonluten supplied by PX1 Research is strictly sold as a research compound for in vitro, cell culture, and laboratory research applications only. It is not for human or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.